3-hydroxybutyryl-CoA dehydrogenase variants and methods of use
The present disclosure provides thiolases and polypeptide variants of 3-hydroxybutyryl-CoA dehydrogenase, nucleic acids encoding the same, vectors comprising the nucleic acids, and cells comprising the polypeptide variants and/or thiolase, the nucleic acids, and/or the vectors. The present disclosure also provides methods of making and using the same, including methods for culturing cells, and for the production of various products, including 3-hydroxybutyryl-CoA (3-HB-CoA), 3-hydroxybutyraldehyde (3-HBal), 3-hydroxybutyrate (3-HB), 1,3-butanediol (1,3-BDO), and esters and amides thereof, and products made from any of these.
1. An isolated 3-hydroxybutyryl-CoA dehydrogenase variant of a reference 3-hydroxybutyryl-CoA dehydrogenase, wherein:
(a) (i) the reference 3-hydroxybutyryl-CoA dehydrogenase has the amino acid sequence of SEQ ID NO: 2, and (ii) the 3-hydroxybutyryl-CoA dehydrogenase variant comprises one or more amino acid substitutions relative to SEQ ID NO: 2, and (iii) the one or more substitutions relative to SEQ ID NO: 2 comprise a substitution at position G35 selected from G35A, G35C, G35D, G35E, G35H, G35K, G35L, G35M, G35P, G35S, G35T, G35V, and G35Y, or
(b) (i) the 3-hydroxybutyryl-CoA dehydrogenase variant comprises one or more amino acid substitutions relative to SEQ ID NO: 2, the one or more amino acid substitutions comprise a substitution at position G35 selected from G35A, G35C, G35D, G35E, G35H, G35K, G35L, G35M, G35P, G35S, G35T, G35V, and G35Y, and (iii) has, other than the substitution at position G35, and
(ii) the 3-hydroxybutyryl-CoA dehydrogenase variant comprises one or more additional amino acid substitutions relative to SEQ ID NO: 2, wherein the one or more additional amino acid substitutions selected from C34, S38, and R40, wherein
(1) The amino acid corresponding to C34 is replaced with A, E, H, I, L, M, S, T, V, or Y;
(2) the amino acid corresponding to S38 is optionally replaced with A, C, D, F, G, H, I, K, L, M, Q, T, V, W, or Y;
(3) the amino acid corresponding to R40 is optionally replaced with D, F, G, H, I, K, L, M, N, P, Q, S, T, V, or Y; or
(4) optionally, two or more of (1)-(3) in any combination; or
(c) (i) the 3-hydroxybutyryl-CoA dehydrogenase variant comprises one or more amino acid substitutions relative to SEQ ID NO: 2, the one or more amino acid substitutions comprise a substitution at position G35 selected from G35A, G35C, G35D, G35E, G35H, G35K, G35L, G35M, G35P, G35S, G35T, G35V, and G35Y, and (iii) has, other than the substitution at position G35, a sequence having at least 85% identity to SEQ ID NO: 2; and
(ii) the 3-hydroxybutyryl-CoA dehydrogenase variant comprises 1, 2, 3, 4, 5, or more additional amino acid substitutions relative to SEO ID NO: 2 selected from: A103M, A107V, A156S, A158R, A193R, A204T, C20F, C34A, C34E, C34H, C34I, C34L, C34M, C34S, C34T, C34V, C34Y, D104A, D104E, D104Q, D106H, D129E, D236C, D236V, E215H, E215W, E42Q, E46C, E46S, E78K, F55I, G241G, G90V, K2090, L160A, L160M, L167Q, L213N, L243A, L243I, L243V, N112C, N112D, N112H, P207Q, Q1440, Q47L, O47L, Q480, R40D, R40F, R40G, R40H, R40I, R40K, R40L, R40M, R40N, R40P, R40Q, R40S, R40T, R40V, R40Y, R41H, R98C, S115R, S38A, S38C, S38D, S38E, S38F, S38G, S38H, S38I, S38K, S38L, S38M, S38Q, S38T, S38V, S38W, S38Y, T114C, T155C, T173S, T205N, T205Q, T92H, T92N, V203I, and V31I.
2. A method of use of the 3-hydroxybutyryl-CoA dehydrogenase variant of claim 1 as a biocatalyst.
3. A composition comprising the 3-hydroxybutyryl-CoA dehydrogenase variant of claim 1 and at least one substrate for said polypeptide variant.
4. A method for producing 3-hydroxybutyryl-CoA (3-HB-CoA), 3-hydroxybutyraldehyde (3-HBal), 3-hydroxybutyrate (3-HB), 1,3-butanediol (1,3-BDO), and/or an ester or amide thereof, the method comprising providing a substrate for the 3-hydroxybutyryl-CoA dehydrogenase variant of claim 1 , and converting the substrate to 3-HB-CoA, 3-HBal, 3-HB, or 1,3-BDO through one or more reactions
wherein the 3-hydroxybutyryl-CoA dehydrogenase variant is isolated and
wherein the 1,3-BDO is optionally at least about 10%, 25%, 50%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or 100% R-1,3-butanediol (R-1,3-BDO).
5. A method for producing the 3-hydroxybutyryl-CoA dehydrogenase variant of claim 1 , the method comprising isolating the 3-hydroxybutyryl-CoA dehydrogenase variant.
6. The isolated 3-hydroxybutyryl-CoA dehydrogenase variant of claim 1 , wherein the 3-hydroxybutyryl-CoA dehydrogenase variant convert acetoacetyl-CoA to 3-hydroxybutyryl-CoA; and/or wherein the 3-hydroxybutyryl-CoA dehydrogenase variant of (a)-(d) is optionally a 3-hydroxybutyryl-CoA dehydrogenase having an increased ability to utilize NADH as a cofactor in a reaction converting acetoacetyl-CoA to 3-hydroxybutyryl-CoA, relative to a reference 3-hydroxybutyryl-CoA dehydrogenase encoded by SEQ ID NO: 2.
7. The composition of claim 3 , wherein said 3-hydroxybutyryl-CoA dehydrogenase variant can react with said substrate under in vitro conditions.
8. The composition of claim 7 , wherein the substrate is acetoacetyl-CoA.
9. The composition of claim 3 , wherein the composition further comprises a thiolase with at least 85% amino acid sequence identity to SEO ID NO: 4.
10. The composition of claim 9 , wherein the thiolase a reduced oxygen sensitivity in converting two acetyl-CoA molecules to acetoacetyl-CoA as compared to a thiolase comprising the amino acid sequence of SEQ ID NO: 6.